Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV brivaracetam as short-term replacement for oral brivaracetam in Japanese adults with partial-onset seizures
jRCT2080224076Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in Focal onset seizure and epilepsy, sponsored by UCB. Started Oct 2018; status: completed.
02
Drugs
brivaracetam
03
Conditions
Focal onset seizureepilepsy
Beyond the preview
Go deeper on jRCT2080224076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224076.